Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precision Therapeutics developed ChemoFx®, a laboratory test that predicts how an individual patient's cancer cells will respond to different chemotherapy agents before treatment begins. Clinical trials have shown improved overall survival and progression-free survival when ChemoFx was used to guide therapy selection. The company also offered CRO services leveraging AI-driven analytics of multiomic data from patient-derived tumor models.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Precision Therapeutics.